Safety and efficacy of 0.01% and 0.1% low-dose atropine eye drop regimens for reduction of myopia progression in Danish children: a randomized clinical trial examining one-year effect and safety

BACKGROUND: To investigate the efficacy and safety of 0.1% and 0.01% low-dose atropine eye drops in reducing myopia progression in Danish children. METHODS: Investigator-initiated, placebo-controlled, double-masked, randomized clinical trial. Ninety-seven six- to twelve-year old myopic participants...

Descripción completa

Detalles Bibliográficos
Autores principales: Hansen, Niklas Cyril, Hvid-Hansen, Anders, Møller, Flemming, Bek, Toke, Larsen, Dorte Ancher, Jacobsen, Nina, Kessel, Line
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10614417/
https://www.ncbi.nlm.nih.gov/pubmed/37904082
http://dx.doi.org/10.1186/s12886-023-03177-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10614417/
https://www.ncbi.nlm.nih.gov/pubmed/37904082
http://dx.doi.org/10.1186/s12886-023-03177-9

Ejemplares similares